Gerard Platenburg - PROQR THERAPEUTICS Insider

PROQR THERAPEUTICS EO 04 -- Germany Stock  

EUR 2.34  0.03  1.27%

Co-Founder, Chief Innovation Officer

Mr. Gerard Platenburg is a CoFounder, Chief Innovation Officer of ProQR Therapeutics NV. He served as the sole Member of the Company Supervisory Board between August 2012 and December 2013. He has more than twenty years of senior managerial experience, which he gained during his different operational and leadership roles in growing biotech companies. Prior to joining the Company, Mr. Platenburg worked at Isa Pharmaceuticals B.V. from June 2009 to January 2014. Mr. Platenburg cofounded Prosensa Holding N.V., growing it to become a wellknown RNA modulation clinical stage company, and held various positions between April 2002 and May 2009, including Chief Executive Officer and Chief Development Officer. Mr. Platenburg also worked at Pharming B.V. from April 1990 to March 2002. He is a passionate and driven pioneer of early stage technologies
Age: 49        
Platenburg has a master degree in chemistry and molecular biology from Leiden University in 1987 and pursued PhD work at Leiden University.

Management Efficiency

Entity Summary

PROQR THERAPEUTICS EO 04 (0PQ) is traded on Frankfurt Stock Exchange in Germany. and employs 5 people.

Did you try this?

Run Commodity Channel Index Now
   

Commodity Channel Index

Use Commodity Channel Index to analyze current equity momentum
Hide  View All  NextLaunch Commodity Channel Index
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add PROQR THERAPEUTICS EO 04 to your portfolio

Top Management

PROQR THERAPEUTICS EO Leadership Team
Daniel Boer, CEO
Rene Beukema, Executive
David Rodman, Executive
Gerard Platenburg, Founder
Smital Shah, CFO, MBA
Noreen Henig, Executive

Stock Performance

PROQR THERAPEUTICS Performance Indicators